hims semaglutide california GLP-1 Weight Loss Guide 2026: Injectable and Oral Treatment Options for Men (Semaglutide and Tirzepatide) Hims & Hers withdraws from

Trial Metric Retatrutide 12mg (TRIUMPH-4) Semaglutide 2.4mg (STEP 1) Mean Weight Loss 28.7% at 68 weeks 14.9% at 68 weeks Mechanism Triple agonist (GLP-1/GIP/GCGR) Single agonist (GLP-1) FDA Status Phase 3 (investigational) Approved (Wegovy) Dosing Weekly subcutaneous Weekly subcutaneous Common Adverse Events GI (nausea, vomiting, diarrhea), dysesthesia GI (nausea, vomiting, diarrhea) Important caveat: These results come from different trial populations and study designs

Youll also need to take lifelong vitamin supplements as youll be eating less food and will be at risk of nutritional deficiencies

Week-by-week changes tend to follow a pattern: minimal change in week one as the medication enters your system, subtle appetite changes in week two, and measurable weight decline by weeks three and four

It may have other effects in the body that we dont completely understand yet

Genetic Testing and Personalized Duration Planning with PlexusDx Not everyone's body responds to or requires the same duration of semaglutide therapy

Researchers interested in the broader metabolic research landscape can explore our best peptides for weight loss research guide for context on available research compounds